Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 16.75
+0.48 (2.95%)
Jun 18, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 8.68 billion as of June 18, 2026.
Market Cap
8.68B
Enterprise Value
7.95B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.75
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 8.68B, a decrease of -36.31%. That is a compound annual growth rate of -48.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 8.68B | -76.24% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Consun Pharmaceutical Group | 11.21B |
| CanSino Biologics | 9.60B |
| Shandong Xinhua Pharmaceutical Company | 8.03B |
| Luye Pharma Group | 7.91B |
| Sihuan Pharmaceutical Holdings Group | 7.87B |
| CF PharmTech | 7.72B |
| China Traditional Chinese Medicine Holdings Co. | 7.20B |